EPHX2 and Alzheimer disease: Another study examining lipid mediators in plasma and cerebrospinal fluid between AD and healthy individuals, including analysis with strong predictive and discriminant models, identified differences in CYP/sEH and acylethanolamide metabolism that could serve as predictors of AD.